Korea Arlico Pharm President Kim Dae Hoon Reports 17-Share Holding, 0.0001% Stake
Bitget2026/10/15 01:26- Korea Arlico Pharm President Kim Dae Hoon disclosed an initial holding of 17 common shares as of October 15, 2026.
- The disclosure followed his appointment as a registered executive on September 11, 2026.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
British Pound: Wider trading range expected against US Dollar – UOB
British Pound holds gains as UK GDP and Industrial Production beat expectations
UBS: Resumes coverage of Regeneron Pharmaceuticals (REGN.US) with a "Buy" rating; potential of blockbuster drug Dupixent underestimated
UBS has resumed coverage of Regeneron Pharmaceuticals (REGN.US) with a "Buy" rating and a target price of $978.
IMF sounds the alarm: Energy shocks and rising US Treasury yields pose spillover risks, Asia’s growth may slow to 4.4% next year
The IMF has lowered its growth forecast for Asia to 4.4% for next year, warning of three major risks: energy shocks, a correction in the AI boom, and rising global yields. The IMF also urged central banks to focus on price stability and avoid broad-based fuel subsidies.
Crypto prices
More
